BIOGNOSYS
DEAD

Serial Number

86960274

Owner

Grushkin, Barry

Attorney

Daniel Gluck

First Use Date

Aug 1, 2007

Filing Date

Mar 31, 2016

Add to watchlist:

No watchlists yet
View on USPTO

BIOGNOSYS Trademark

Serial Number: 86960274

BIOGNOSYS is a trademark filed by Grushkin, Barry on March 31, 2016. The trademark is classified under Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Grushkin, Barry

BioGnosys
New York, NY 10025

Entity Type: 01

Trademark Details

Filing Date

March 31, 2016

Registration Date

Not Registered

First Use Anywhere

August 1, 2007

First Use in Commerce

August 1, 2007

Published for Opposition

February 28, 2017

Goods & Services

(Based on Use in Commerce) Charitable services, namely, providing medical equipment and services to underserved communities; Medical information services, namely, reporting of consumer authorized clinical testing results directly to the patient; Medical testing for diagnostic or treatment purposes in the field of autism spectrum disorders (ASD), Aspergers Syndrome, attention deficit disorders, ADHD, and fibromyalgia; Medical testing of urine, blood, hair follicles and breath; Medical diagnostic testing, monitoring and reporting services; Performing diagnosis of diseases; Providing medical information; Providing medical information in the field of urine analysis and diagnosis of autism spectrum disorder, Aspergers Syndrome, attention deficit disorders, ADHD, and fibromyalgia; Providing medical information to patients and medical professionals in the form of reports in the field of urine analysis and diagnosis of autism spectrum disorder, Aspergers Syndrome, attention deficit disorders, ADHD, and fibromyalgia; Providing personalized healthcare and medical information in the nature of urine analysis and diagnosis of autism spectrum disorder, Aspergers Syndrome, attention deficit disorders, ADHD, and fibromyalgia; Remote monitoring of data indicative of the health or condition of an individual or group of individuals for medical diagnosis and treatment purposes; Consulting services in the fields of diagnostic medical testing and nutrition; Medical diagnosis of autism spectrum disorder, Aspergers Syndrome, attention deficit disorders, ADHD, and fibromyalgia; Medical screening; Mental health screening services; Providing medical information, consultancy and advisory services; (Based on Intent to Use) Providing an on-line, patient-initiated, patient-authorized, fee-for-service, medical profile and medical record analysis service designed to provide patients with custom tailored information about the range of possible diagnoses and therapies associated with a defined set of symptoms; Providing on-line medical record analysis services designed to provide patients with custom tailored information about the range of possible diagnoses and therapies associated with a defined set of symptoms; Providing medical profiles and medical record analysis and assessments via a website that are designed to provide custom tailored outputs about recommended resources and treatments associated with a defined set of symptoms and concerns; Providing a website featuring information in the field of the diagnosis and treatment of autism spectrum disorder, Aspergers Syndrome, attention deficit disorders, ADHD, and fibromyalgia; Providing an internet website featuring news and information relating to diagnosis and treatment of autism

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Mar 26, 2018 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Mar 26, 2018 ABN6
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 22, 2017 NOAM
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Jul 9, 2017 ETOP
EXTENSION OF TIME TO OPPOSE RECEIVED
Mar 28, 2017 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 28, 2017 NPUB
PUBLISHED FOR OPPOSITION
Feb 28, 2017 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 8, 2017 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 25, 2017 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 24, 2017 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 24, 2017 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 24, 2017 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 24, 2017 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 20, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 19, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 19, 2017 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 21, 2016 GNRN
NON-FINAL ACTION E-MAILED
Jul 21, 2016 GNRT
NON-FINAL ACTION WRITTEN
Jul 21, 2016 CNRT
ASSIGNED TO EXAMINER
Jul 14, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 5, 2016 NWOS
NEW APPLICATION ENTERED
Apr 4, 2016 NWAP